XML 15 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share Based Compensation (Details) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Stock Options [Member]
Sep. 30, 2012
Restricted Stock [Member]
Sep. 30, 2012
Director [Member]
Sep. 30, 2011
Director [Member]
Mar. 31, 2012
President [Member]
Mar. 31, 2011
Chief Executive Officer [Member]
Sep. 30, 2012
Executive Officers [Member]
Mar. 31, 2011
Executive Officers [Member]
Sep. 30, 2012
Non-Employee Directors [Member]
Sep. 30, 2011
Non-Employee Directors [Member]
Sep. 30, 2012
Non-Employee Directors [Member]
Sep. 30, 2011
Non-Employee Directors [Member]
Sep. 30, 2012
Officer [Member]
Salary Stock Arrangement with Individual, Share-based Payments [Line Items]                                  
Number of additional shares approved for grant (in shares)     200,000                       300,000    
Annual salary increase                 $ 30,000 $ 200,000              
Restricted stock units issued to executives (in shares)                     220,000 140,000          
Number of executive issued restricted stock                     6 5          
Award vesting period, minimum                     3 years 2 years         3 years
Shares granted, expiry period 10 years                                
Stock options issued to officers (in shares)                                 100,000
Shares issues as retainer fees (in shares)             170,000 80,000                  
Total compensation expense (recovery) recognized 200,000 300,000 300,000 700,000                          
Non-employee directors share-based compensation expenses                         100,000 100,000 300,000 200,000  
Total compensation cost not yet recognized 1,400,000   1,400,000                            
Total compensation cost not yet recognized, period for recognition     2 years 9 months 18 days                            
Outstanding stock option grants and transaction [Roll Forward]                                  
Outstanding, beginning balance (in shares)         180,862                        
Granted (in shares)         113,400                        
Exercised (in shares)         (1,401)                        
Forfeited (in shares)         (11,666)                        
Expired (in shares)         (5,495)                        
Outstanding, ending balance (in shares)         275,700                        
Vested and expected to vest, period end (in shares)         253,972                        
Exercisable, period end (in shares)         77,881                        
Weighted Average Exercise Price [Roll Forward]                                  
Outstanding, beginning balance (in dollars per share)         $ 7.98                        
Granted (in dollars per share)         $ 2.70                        
Exercised (in dollars per share)         $ 1.92                        
Forfeited (in dollars per share)         $ 1.92                        
Expired (in dollars per share)         $ 90.66                        
Outstanding, ending balance (in dollars per share)         $ 4.45                        
Vested and expected to vest, period end (in dollars per share)         $ 4.62                        
Exercisable, period end (in dollars per share)         $ 9.73                        
Weighted-Average Remaining Contractual Term [Abstract]                                  
Outstanding, Weighted Average Remaining Contractual Term         8 years 8 months 1 day                        
Vested and Expected to Vest, Weighted-Average Remaining Contractual Term         8 years 7 months 6 days                        
Exercisable, Weighted Average Remaining Contractual Term         7 years 14 days                        
Aggregate intrinsic value [Abstract]                                  
Outstanding, Intrinsic Value         100,000                        
Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value         94,000                        
Exercisable, Aggregate Intrinsic Value         32,000                        
Non-vested restricted stock and stock units and transactions [Roll Forward]                                  
Outstanding, beginning balance (in shares)           165,045                      
Granted (in shares)           221,147                      
Vested (in shares)           (4,496)                      
Forfeited (in shares)           (522)                      
Outstanding, ending balance (in shares)           381,174                      
Weighted Average Grant Date Fair Value [Roll Forward]                                  
Outstanding, beginning balance (in dollars per share)           $ 17.90                      
Granted (in dollars per share)           $ 2.78                      
Vested (in dollars per share)           $ 166.90                      
Forfeited (in dollars per share)           $ 93.14                      
Outstanding, ending balance (in dollars per share)           $ 7.27                      
Weighted-average assumptions used [Abstract]                                  
Expected dividend yield (in hundredths)     0.74%                            
Risk-free interest rate (in hundredths)     0.88%                            
Expected life     6 years                            
Expected volatility (in hundredths)     100.00%                            
Per share weighted-average fair value (in dollars per share) $ 2.02   $ 2.02                            
Information regarding options exercised [Abstract]                                  
Intrinsic value 1,000 0 1,000 0                          
Cash proceeds received 3,000 0 3,000 0                          
Tax benefit realized $ 0 $ 0 $ 0 $ 0